Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy
Authors:
- Yoko SatohYSYoko Satoh
- Atsushi NambuANAtsushi Nambu
- Hiroshi OnishiHOHiroshi Onishi
- Eiichi SawadaESEiichi Sawada
- Licht TominagaLTLicht Tominaga
- Kengo KuriyamaKKKengo Kuriyama
- Takafumi KomiyamaTKTakafumi Komiyama
- Kan MarinoKMKan Marino
- Shinichi AokiSAShinichi Aoki
- Masayuki ArayaMAMasayuki Araya
- Ryo SaitoRSRyo Saito
- Yoshiyasu MaehataYMYoshiyasu Maehata
- 1 November 2012
- journal article
- clinical trial
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (11) , 3530-3534
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Maximum Standardized Uptake Value From Staging FDG-PET/CT Does not Predict Treatment Outcome for Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic areaSouth African Medical Journal, 2010
- The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung CarcinomaLung Cancer, 2010
- Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2010
- Standard Uptake Value Predicts Survival in Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 2009
- Efficacy comparison between 18F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancerLung Cancer, 2009
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancerLung Cancer, 2007
- Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinomaCancer, 2006
- Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancerNuclear Medicine Communications, 2005